FDA OKs Phase 3 Trial of Masitinib for Progressive Forms of MS
By Lindsey Shapiro, PhD on 01/03/2023 The U.S. Food and Drug Administration (FDA) has cleared AB Science to initiate a Phase 3…
Antidepressant Bupropion Found to Ease Sexual Dysfunction in MS
Dec 2022 Daily treatment with an oral antidepressant called bupropion — marketed as Wellbutrin and Zyban, among others — significantly improved some…
Stuart Schlossman
Under the microscope: what is the potential of BTK inhibitors (BTKI) ?
information provided by: MS Society UK Bruton’s tyrosine kinase (BTK) inhibitors are an emerging type of disease modifying therapy (DMT)…
Stuart Schlossman
The MS wealth death gap. Rich people with MS are 16.6% more likely to be alive after 30 years compared with poor people with MS [according to this observational study in France].
Abstract Background: The effects of socio-economic status on mortality in patients with multiple sclerosis is not well known. The objective…
Stuart Schlossman
Can diabetes drugs like insulin, metformin affect MS risk?
Medical New Today By Hannah Flynn on November 24, 2022 — Fact checked by Anna Guildford, Ph.D. …
Stuart Schlossman
Time to reconsider the classification of multiple sclerosis
author: Takashi Yamamura November 18, 2022 Multiple sclerosis is an inflammatory demyelinating disease of the CNS, showing various clinical manifestations…
Stuart Schlossman
Multiple sclerosis progression: time for a new mechanism-driven framework
Published: November 18, 2022 Prof Tanja Kuhlmann, MD Marcello Moccia, MD Timothy Coetzee, PhD * Prof Jeffrey A Cohen, MD * Prof…
Stuart Schlossman
Researchers seek to know why stem cell treatment works
November 14, 2022 A new study from Switzerland suggests why stem cell transplant works. The treatment is particularly suitable for…
Stuart Schlossman
Brain discovery may help boost body’s ability to fight MS
Researchers may have discovered a molecule in the brain responsible for orchestrating the immune system’s responses to multiple sclerosis. The…
Stuart Schlossman
Obesity and MS
News Flash! According to the German National MS study of 1066 German participants with relapsing-remitting MS, those considered obese had…
Stuart Schlossman
